Want to track OMCL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 61 days
Omnicell (OMCL) Surpasses Q2 Earnings and Revenue Estimates
Omnicell (OMCL) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.57 per share a year ago.
Zacks | 1 year ago
Omnicell (OMCL) Expected to Beat Earnings Estimates: Should You Buy?
Omnicell (OMCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks | 1 year ago
Omnicell (OMCL) Banks on Product Launches, Global Growth
Omnicell (OMCL) remains a key player in automating and modernizing global medication management infrastructure.
Zacks | 1 year ago
Here's Why Omnicell (OMCL) Should be in Your Portfolio Now
A robust Advanced Services portfolio and strategic restructuring initiatives bode well for Omnicell (OMCL).
Zacks | 1 year ago
Omnicell (OMCL) Gains From New Offerings Amid Cost Woes
With the EnlivenHealth platform, Omnicell (OMCL) is gaining momentum with cross-selling and up-selling communication solutions to existing customers.
Zacks | 1 year ago
2025 © Marketlog. All Rights Reserved.
